학술논문
Does the Time to Start First-Line Treatment Influence the Survival of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma? Results of the MetaSurv–UroCCR 79 Study
Document Type
Article
Author
Source
In Clinical Genitourinary Cancer February 2023 21(1):194-202
Subject
Language
ISSN
1558-7673